Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.
Johannes CB, Ziemiecki R, Pladevall-Vila M, Ebert N, Kovesdy CP, Thomsen RW, Baak BN, García-Sempere A, Kanegae H, Coleman CI, Walsh M, Andersen IT, Rodríguez Bernal C, Robles Cabaniñas C, Christiansen CF, Farjat AE, Gay A, Gee P, Herings RMC, Hurtado I, Kashihara N, Kristensen FPB, Liu F, Okami S, Overbeek JA, Penning-van Beest FJA, Yamashita S, Yano Y, Layton JB, Vizcaya D, Oberprieler NG.
Johannes CB, et al. Among authors: yamashita s.
Diabetes Ther. 2024 Dec 17. doi: 10.1007/s13300-024-01671-x. Online ahead of print.
Diabetes Ther. 2024.
PMID: 39688776